DER SHENG SUN

Prof. Dr. DER SHENG SUN

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JLJung Soo Lee
Jung Soo Lee
Young-Ho AhnYoung-Ho Ahn
Young-Ho Ahn
HWHye Sung Won
Hye Sung Won
DSDER SHENG SUN
DER SHENG SUN
YKYeo Hyung Kim
Yeo Hyung Kim
YKYoon Ho Ko
Yoon Ho Ko
Background/Aims.The miRNA-200 (miR-200) family may act as key inhibitors of epithelial-to-mesenchymal transition. However, the potential prognostic value of miR-200s in various human malignancies remains controversial. This meta-analysis analyzed the associations between miR-200 levels and survival outcomes in a variety of tumors.Methods.Eligible published studies were identified by searching the Embase, PubMed, CINAHL, and Google scholar databases. Patient clinical data were pooled, and pooled hazard ratios (HRs) with 95% confidence intervals (95% CI) were used to calculate the strength of this association.Results.The pooled HRs suggested that high tissue expression of miR-200 family members was associated with better survival (overall survival [OS]: HR = 0.70, 95% CI 0.54–0.91; progression-free survival [PFS]: HR = 0.63, 95% CI 0.52–0.76) in thirty-four eligible articles. In contrast, higher expression of circulating miR-200 members was significantly associated with poor clinical outcome (OS, HR = 1.68, 95% CI 1.15–2.46; PFS, HR = 2.62, 95% CI 1.68–4.07).Conclusion.The results from this meta-analysis suggest that miR-200 family members are potential prognostic biomarkers in patients with various carcinomas. To apply these findings in the clinic, large prospective studies are needed to validate the prognostic values of miR-200s in individual cancer types.

12 July 2022 in Medicina
Verified
Journal Article
Open access
PDF file
Kwangil YimKwangil Yim
Kwangil Yim
WJWon Mo Jang
Won Mo Jang
UCUiju Cho
Uiju Cho
DSDER SHENG SUN
DER SHENG SUN
Yosep ChongYosep Chong
Yosep Chong
KSKyung Jin Seo
Kyung Jin Seo
Background and Objectives: The prediction of the prognosis and effect of neoadjuvant therapy is vital for patients with advanced or unresectable colorectal carcinoma (CRC). Materials and Methods: We investigated several tumor microenvironment factors, such as intratumoral budding (ITB), desmoplastic reaction (DR), and Klintrup–Mäkinen (KM) inflammation grade, and the tumor–stroma ratio (TSR) in pretreatment biopsy samples (PBSs) collected from patients with advanced or unresectable CRC. A total of 85 patients with 74 rectal carcinomas and 11 colon cancers treated at our hospital were enrolled; 66 patients had curative surgery and 19 patients received palliative treatment. Results: High-grade ITB was associated with recurrence (p = 0.002), death (p = 0.034), and cancer-specific death (p = 0.034). Immature DR was associated with a higher grade of clinical tumor-node-metastasis stage (cTNM) (p = 0.045), cN category (p = 0.045), and cM category (p = 0.046). The KM grade and TSR were not related to any clinicopathological factors. High-grade ITB had a significant relationship with tumor regression in patients who received curative surgery (p = 0.049). Conclusions: High-grade ITB in PBSs is a potential unfavorable prognostic factor for patients with advanced CRC. Immature DR, TSR, and KM grade could not predict prognosis or therapy response in PBSs.

17 May 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SCSang Hoon Chun
Sang Hoon Chun
EKEun Young Kim
Eun Young Kim
JYJung-Sook Yoon
Jung-Sook Yoon
HWHye Sung Won
Hye Sung Won
Kwangil YimKwangil Yim
Kwangil Yim
YKYoon Ho Ko
Yoon Ho Ko
Background: Noggin and RNA-binding protein for multiple splicing 2 (RBPMS2) are known to regulate the expression of smooth muscle cells, endothelial cells, and osteoblasts. However, the prognostic role of combined Noggin and RBPMS2 expression in resected gastric cancer (GC) is unclear. Methods: A total of 163 patients with GC who underwent gastrectomy were included in this study. The expression of Noggin and RBPMS2 proteins in tumor cells at the tumor center and invasive front of resected GC was evaluated by immunohistochemistry, and in conjunction with clinicopathological parameters the patient survival was analyzed. Results: RBPMS2 protein expression was high at the tumor center (n = 86, 52.8%) and low at the invasive front (n = 69, 42.3%), while Noggin protein expression was high in both tumor center (n = 91, 55.8%) and the invasive front (n = 90, 55.2%). Noggin expression at the invasive front and tumor center was significantly decreased in advanced T stage, non-intestinal-type (invasive front, P = 0.008 and P < 0.001; tumor center lesion, P = 0.013 and P = 0.001). RBPMS2 expression at the invasive front was significantly decreased in non-intestinal-type and positive lymphatic invasion (P < 0.001 and P = 0.013). Multivariate analysis revealed that high Noggin protein expression of the invasive front was an independent prognostic factor for overall survival (hazard ratio [HR], 0.58; 95% confidence interval [CI]; 0.35–0.97, P < 0.036), but not at the tumor center (HR, 1.35; 95% CI; 0.81–2.26, P = 0.251). Conclusions: Our study indicates that high Noggin expression is a crucial prognostic factor for favorable outcomes in patients with resected GC.

1 January 2023 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
GLGuk Jin Lee
Guk Jin Lee
HKHyunho Kim
Hyunho Kim
SCSung Shim Cho
Sung Shim Cho
HPHyung Soon Park
Hyung Soon Park
HAHo Jung An
Ho Jung An
BSByoung Yong Shim
Byoung Yong Shim
Lee GJ, et al. J Gastric Cancer. 2023 Mar;23:e16. https://doi.org/10.5230/jgc.2023.23.e16

26 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DLDong Soo Lee
Dong Soo Lee
CKChang Wook Kim
Chang Wook Kim
HKHEE YEON KIM
HEE YEON KIM
YKYoung-Mi Ku
Young-Mi Ku
YWYoo Dong Won
Yoo Dong Won
DSDER SHENG SUN
DER SHENG SUN
Background: We sought to investigate whether serum immune and inflammatory parameters can help to predict distant metastasis (DM) in patients with unresectable hepatocellular carcinoma (HCC) undergoing curative radiation therapy (RT). Methods: A total of 76 RT courses were analyzed. The following variables were included in the analysis: systemic inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio (PLR), prognostic nutritional index (PNI), absolute lymphocyte count, lymphocyte-to-monocyte ratio, albumin, albumin-to-alkaline phosphatase ratio, RT-related parameters, and levels of total protein, hemoglobin, α-fetoprotein, and PIVKA-II. Distant control (DC) and overall survival (OS) rates were calculated and compared. Results: The mean age was 61.4 years, and most patients were men (n = 62, 81.6%). The median RT fraction number and fractional doses were 12 (range, 4–30) and 5 (range, 2–12) Gy, respectively. With a median follow-up of 12 (range, 3.1–56.7) months, the 1-year DC and OS rates were 64.4% and 55.2%, respectively. The development of DM significantly deteriorated OS (p = 0.013). In the multivariate analysis, significant independent prognostic indicators for DC and OS rates were the highest posttreatment PLR (≤235.7 vs. >235.7, p = 0.006) and the lowest posttreatment PNI (≤25.4 vs. >25.4, p < 0.001), respectively. Conclusions: Posttreatment serum PLR might be helpfully used as a predictive biomarker of DM in unresectable HCC patients undergoing RT. Future research is necessary to confirm our findings.

28 May 2018 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
DSDER SHENG SUN
DER SHENG SUN
HLHae Kyung Lee
Hae Kyung Lee
YKYonggoo Kim
Yonggoo Kim
JLJe Hoon Lee
Je Hoon Lee
HWHye Sung Won
Hye Sung Won
HKHyun Jung Kim
Hyun Jung Kim
Sun DS, et al. Ann Lab Med. 2018 May;38(3):274-276. https://doi.org/10.3343/alm.2018.38.3.274